Back to Results
First PageMeta Content
Health / Sleep disorders / Benzofurans / Cyclopropanes / Sedatives / Tasimelteon / European Medicines Agency / Non-24-hour sleep-wake disorder / Committee for Medicinal Products for Human Use / Circadian rhythms / Chemistry / Biology


23 April 2015 EMA/CHMPCommittee for Medicinal Products for Human Use (CHMP) Summary of opinion 1 (initial authorisation)
Add to Reading List

Document Date: 2015-04-24 07:03:59

Open Document

File Size: 65,11 KB

Share Result on Facebook

City

London / /

Company

Vanda Pharmaceuticals Ltd. / /

Country

United Kingdom / /

Facility

Canary Wharf / /

IndustryTerm

medicinal product / orphan medicinal product / /

MedicalCondition

headache / sleep-wake disorder / /

Organization

Committee for Medicinal Products for Human Use / European Union / European Medicines Agency / contact An / European Commission / /

/

PublishedMedium

the European / /

URL

www.ema.europa.eu/contact / /

SocialTag